Amicus Capital

Amicus Capital is a seed-stage venture capital firm based in San Francisco, United States, focusing on early-stage investments in technology and life sciences companies. The firm seeks to partner with entrepreneurs who are solving problems in large markets, aiming to support innovative solutions with high growth potential.

The firm's investment strategy emphasizes identifying disruptive innovations that drive significant growth, particularly in sectors such as technology, life sciences, and health tech. Amicus Capital typically invests between $500,000 and $2 million in each portfolio company, providing capital to support the scaling and development of promising startups.

With a team experienced in leading over 50 deals across North America and Europe, Amicus Capital is known for its hands-on approach, achieving successful exits through strategic partnerships and operational improvements. The firm leverages its deep industry insights and strong network to support its portfolio companies in realizing their global potential.